Literature DB >> 12414071

Auditory P300 amplitude as a state marker for positive symptoms in schizophrenia: cross-sectional and retrospective longitudinal studies.

Masato Higashima1, Tatsuya Nagasawa, Yasuhiro Kawasaki, Takashi Oka, Naoto Sakai, Takahiro Tsukada, Yoshifumi Koshino.   

Abstract

The amplitude of the P300 component of the auditory event-related brain potential (ERP) is consistently reduced in schizophrenia. To determine whether this P300 abnormality can be used as a state marker to reflect the severity of symptoms, we examined both cross-sectionally and longitudinally the relationship between auditory P300 amplitude and symptom severity in patients with schizophrenia. For the cross-sectional study, ERP was elicited by an auditory oddball paradigm, and symptom severity was quantitatively measured by means of the Positive and Negative Syndrome Scale in 93 patients with schizophrenia or schizophreniform disorder (DSM-III-R). For the longitudinal study, ERP and psychopathology measured twice at an average interval of 238 days for 20 patients were retrospectively analyzed. The cross-sectional data showed that P300 amplitude correlated negatively with the positive but not with the negative syndrome scale score. The longitudinal data also showed a significant negative correlation between changes in P300 amplitude and in the positive syndrome scores of the first and second tests. In particular, P300 amplitude recorded at the left, but not right, posterior temporal region significantly correlated with the positive syndrome in both the cross-sectional and longitudinal studies. These findings support the hypotheses that auditory P300 amplitude recorded in the left hemisphere can be used as a state marker to reflect the severity of the positive symptoms and that the positive symptoms may be caused by a possible left-hemisphere deficit in schizophrenia. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12414071     DOI: 10.1016/s0920-9964(01)00397-8

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  6 in total

1.  Effects of etizolam and ethyl loflazepate on the P300 event-related potential in healthy subjects.

Authors:  Goro Fukami; Tasuku Hashimoto; Yukihiko Shirayama; Tadashi Hasegawa; Hiroyuki Watanabe; Mihisa Fujisaki; Kenji Hashimoto; Masaomi Iyo
Journal:  Ann Gen Psychiatry       Date:  2010-11-03       Impact factor: 3.455

2.  P300 amplitude and latency in autism spectrum disorder: a meta-analysis.

Authors:  Tingkai Cui; Peizhong Peter Wang; Shengxin Liu; Xin Zhang
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-06-14       Impact factor: 4.785

3.  Progressive reduction of visual P300 amplitude in patients with first-episode schizophrenia: an ERP study.

Authors:  Naoya Oribe; Yoji Hirano; Shigenobu Kanba; Elisabetta Del Re; Larry Seidman; Raquelle Mesholam-Gately; Jill M Goldstein; Martha Shenton; Kevin M Spencer; Robert W McCarley; Margaret Niznikiewicz
Journal:  Schizophr Bull       Date:  2014-06-09       Impact factor: 9.306

4.  A comparative study on long-term evoked auditory and visual potential responses between Schizophrenic patients and normal subjects.

Authors:  Min-Wei Huang; Frank Huang-Chih Chou; Pei-Yu Lo; Kuo-Sheng Cheng
Journal:  BMC Psychiatry       Date:  2011-05-04       Impact factor: 3.630

5.  Deficit Effect Sizes and Correlations of Auditory Event-Related Potentials at First Hospitalization in the Schizophrenia Spectrum.

Authors:  Dean F Salisbury; Justine Kohler; Martha E Shenton; Robert W McCarley
Journal:  Clin EEG Neurosci       Date:  2019-08-07       Impact factor: 2.046

6.  P300 aberration in first-episode schizophrenia patients: a meta-analysis.

Authors:  Yao-qin Qiu; Yun-xiang Tang; Raymond C K Chan; Xin-yang Sun; Jia He
Journal:  PLoS One       Date:  2014-06-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.